Fig 3.
Mean soluble interleukin-2 receptor levels in serum by dose level pre-infusion and 4 hours after starting infusion (days 1 and 3) and on days 2, 4, 5, and 8 for (A) patients completing course 1 and (B) for patients completing course 2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.